{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:41:04Z","timestamp":1769596864884,"version":"3.49.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ijsu.2019.07.026","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T05:45:51Z","timestamp":1564206351000},"page":"61-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Survival outcomes of ovarian cancer patients treated with secondary cytoreductive surgery for isolated lymph node recurrence: A systematic review of the literature"],"prefix":"10.1097","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4510-1633","authenticated-orcid":false,"given":"Vasilios","family":"Pergialiotis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Androutsou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Papoutsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5088-5458","authenticated-orcid":false,"given":"Ioannis","family":"Bellos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Thomakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Haidopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Rodolakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijsu.2019.07.026_bib1","unstructured":"Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL. CA cancer J. Clin. 10.3322\/caac.21456."},{"issue":"68","key":"10.1016\/j.ijsu.2019.07.026_bib2","first-page":"284","volume":"2018","author":"Torre","year":"2018","journal-title":"Ovarian Cancer Stat."},{"key":"10.1016\/j.ijsu.2019.07.026_bib3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2147\/OTT.S119879","article-title":"Antiangiogenic drugs used with chemotherapy for patients with recurrent ovarian cancer: a meta-analysis","volume":"10","author":"Yi","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ijsu.2019.07.026_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1185\/03007995.2015.1131152","article-title":"Angiogenesis inhibitors for patients with ovarian cancer: a meta-analysis of 12 randomized controlled trials","volume":"32","author":"Li","year":"2016","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ijsu.2019.07.026_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.critrevonc.2018.08.011","article-title":"The Era of PARP inhibitors in ovarian cancer: \"Class Action\" or not? A systematic review and meta-analysis","volume":"131","author":"Staropoli","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib7","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1200\/JCO.2018.36.15_suppl.5501","volume":"36","author":"Coleman","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.clon.2018.04.006","article-title":"When should surgery be used for recurrent ovarian carcinoma?","volume":"30","author":"Bommert","year":"2018","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1471-2407-8-367","article-title":"Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome","volume":"8","author":"Legge","year":"2008","journal-title":"BMC Canc."},{"key":"10.1016\/j.ijsu.2019.07.026_bib10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib11","author":"GA Wells"},{"key":"10.1016\/j.ijsu.2019.07.026_bib12","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(13)62419-8","article-title":"Fetoscopic laser coagulation of the vascular equator versus selective coagulation for twin-to-twin transfusion syndrome: an open-label randomised controlled trial","volume":"383","author":"Slaghekke","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijsu.2019.07.026_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jso.24669","article-title":"The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy","volume":"116","author":"Eoh","year":"2017","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib14","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ejso.2018.08.006","article-title":"Minimally invasive salvage lymphadenectomy in gynecological cancer patients: a single institution series","volume":"44","author":"Gallotta","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1477-7819-11-255","article-title":"Clinical features and outcomes of neck lymphatic metastasis in ovarian epithelial carcinoma","volume":"11","author":"Chen","year":"2013","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.suronc.2013.10.005","article-title":"The impact of pelvic retroperitoneal invasion and distant nodal metastases in epithelial ovarian cancer","volume":"23","author":"Pereira","year":"2014","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1525-1438.2007.00929.x","article-title":"Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery","volume":"17","author":"Benedetti Panici","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ijsu.2019.07.026_bib18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1245\/ASO.2004.11.023","article-title":"Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes","volume":"11","author":"Uzan","year":"2004","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ygyno.2006.10.020","article-title":"Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer","volume":"104","author":"Santillan","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ygyno.2006.06.039","article-title":"Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors","volume":"104","author":"Blanchard","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygyno.2009.04.025","article-title":"Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer","volume":"114","author":"Fotiou","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ygyno.2009.11.008","article-title":"The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study","volume":"116","author":"Gadducci","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib23","first-page":"928","article-title":"[Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence]","volume":"47","author":"Tu","year":"2012","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.ijsu.2019.07.026_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2013.06.020","article-title":"Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors","volume":"131","author":"Petrillo","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ejso.2013.11.026","article-title":"Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: a multicenter study","volume":"40","author":"Ferrero","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ijgo.12667","article-title":"The addition of lymphadenectomy to secondary cytoreductive surgery in comparison with bulky node resection in patients with recurrent ovarian cancer","volume":"143","author":"Bogani","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ijsu.2019.07.026_bib27","first-page":"169","article-title":"Are nodal metastases in ovarian cancer chemoresistant lesions? Analysis of nodal involvement in 105 patients treated with preoperative chemotherapy","volume":"25","author":"Morice","year":"2004","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0950-3552(89)80051-3","article-title":"The effect of chemotherapy on lymph node metastases in ovarian cancer","volume":"3","author":"Burghardt","year":"1989","journal-title":"Bailliere. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib29","doi-asserted-by":"crossref","first-page":"32506","DOI":"10.1038\/srep32506","article-title":"New concept for the prevention and treatment of metastatic lymph nodes using chemotherapy administered via the lymphatic network","volume":"6","author":"Kodama","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijsu.2019.07.026_bib30","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.ultrasmedbio.2013.12.012","article-title":"The combination of intralymphatic chemotherapy with ultrasound and nano-\/microbubbles is efficient in the treatment of experimental tumors in mouse lymph nodes","volume":"40","author":"Sato","year":"2014","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib31","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/carcin\/bgh272","article-title":"Organ-selective chemoresistance in metastasis from human breast cancer cells: inhibition of apoptosis, genetic variability and microenvironment at the metastatic focus","volume":"25","author":"Gu","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ijsu.2019.07.026_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00280-016-2963-4","article-title":"UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy","volume":"77","author":"Zhang","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijsu.2019.07.026_bib33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yexcr.2017.12.029","article-title":"SUSD2 promotes cancer metastasis and confers cisplatin resistance in high grade serous ovarian cancer","volume":"363","author":"Xu","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ijsu.2019.07.026_bib34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijscr.2014.04.017","article-title":"Recurrent ovarian cancer with multiple lymph nodes metastases successfully treated with lymphadenectomy as secondary cytoreductive surgery: a case report","volume":"5","author":"Nagano","year":"2014","journal-title":"Int. J. Surg. Case Rep."},{"key":"10.1016\/j.ijsu.2019.07.026_bib35","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/jog.13947","article-title":"Radiotherapy for isolated recurrent epithelial ovarian cancer: a single institutional experience","volume":"45","author":"Komura","year":"2019","journal-title":"J. Obstet. Gynaecol. Res."}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919119301785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919119301785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T16:05:17Z","timestamp":1677081917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1743919119301785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":35,"alternative-id":["S1743919119301785"],"URL":"https:\/\/doi.org\/10.1016\/j.ijsu.2019.07.026","relation":{},"ISSN":["1743-9191"],"issn-type":[{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival outcomes of ovarian cancer patients treated with secondary cytoreductive surgery for isolated lymph node recurrence: A systematic review of the literature","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijsu.2019.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 IJS Publishing Group Ltd. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}